NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Butterfly Medical

Butterfly Medical

Private
IsraelHealthcare & Life Scienceshttps://butterfly-medical.com/

Last Round

Series C

May 14, 2026

Total Funding Raised

$30.06M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Butterfly Medical is a therapeutic devices company that has developed a proprietary, non-surgical, and minimally invasive solution for the treatment of benign prostatic hyperplasia (BPH).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

BPH treatmentprostatic retraction deviceminimally invasive implantprostatic urethral liftPULBPH implantminimally invasive surgical therapyMISTurology devicereversible implanttissue-sparing procedureUroLift alternativenitinol implantmen's healthMedTechCE Mark

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Butterfly Medical Comps

Public and private peers based on sector, stage, and business model.

Butterfly Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Butterfly Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMay 14, 2026
Series BOct 6, 2020
AngelJan 29, 2020
GrantSep 1, 2019
SeedOct 1, 2014

Key People

Founding team and executive leadership

Adrian Paz

Co - Founder, Chief Medical Officer

Founding Team

Patrick MacCarthy

Chief Executive Officer

Executive Team

Robert Hecktus

Chief Executive Officer

Executive Team

Idan Geva

COO

Executive Team

Butterfly Medical Investors

Notable investors and investment history

Butterfly Medical investors
InvestorRounds
European Innovation Council FundSeries C
MedVenture PartnersSeries C
Junson CapitalSeries C
New Rhein Healthcare InvestorsSeries C, Series B
MassChallenge IsraelGrant
MedVenture Partners, Inc.Series C
Wasatch HealthSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 14, 2026

    $21M round with participation from Junson Capital and Wasatch Health.

  • Apr 5, 2026

    Monthly visitors grew 101% MoM.

Butterfly Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Butterfly Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Butterfly Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range20
Year Founded2014
Last FundingMay 14, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.